Company intelligence / Profile preview

GigaaLaser

Wuhan, Hubei, China
Ownership
Private
Employees
~51
Development stage
Other
01

Overview

GigaaLaser's diode laser platforms are CE and ISO13485 certified, approved for various medical and dental procedures, with widespread international adoption. No pharmaceutical clinical trials; device clinical adoption validated via regulatory milestones[6][7].

Therapeutic areas
CardiovascularNeurologyMen's HealthOtherDermatologyOncology
Modalities
DevicePhotodynamic therapy (PDT)Laser-based therapy
Industry
Therapeutic Medical Devices
02

Partnerships

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (for ALA-PDT)[6]academic partnerships including EVLA training in Zhongshan Hospital, Wuhan[2]

Beyond the preview

Go deeper on GigaaLaser.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GigaaLaser.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call